LexaGene is a biotechnology company developing automated and sensitive instrumentation for rapid pathogen detection.
Our breakthrough technology will transform how pathogens are detected and deliver results in about an hour.
15 August 2017 – LexaGene names life sciences veteran Manohar Furtado to the board of directors. New director brings extensive human health and safety leadership experience to the company.
Innovation in the Making
Imagine a new way of testing on site for multiple pathogens that uses customized genetic screening, doesn’t requite a skilled technician,
and returns results in just one hour. See what’s new with LexaGene and how we are changing the future of pathogen detection.
Introducing the LX6
At a recent conference, LexaGene unveiled our LX6 alpha prototype to get early feedback from the food safety market.
We are commercializing the first ‘open-access’ instrument for pathogen detection, allowing users an on-site instrument to target any gene sequence of interest, and return results in about an hour.
LexaGene on Fox
Tune in to watch a feature on LexaGene airing soon on Fox Business Network!
Saturday 26 August @ 5pmET and 9 September @ 5pmET
Food industry news site Food Quality News featured LexaGene in a recent article, interviewing Dr. Jack Regan about the expected applications of the technology in the food processing market and beyond.